Skip to search.
 TSX Down 0.67% TSX Ventures Up 0.03%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
0.39 Down 0.01(1.28%) Sep 23, 4:00PM EDT
Prev Close:0.39
Open:0.40
Bid:0.30 x 1000
Ask:0.43 x 5000
1y Target Est:1.92
Beta:0.426822
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:0.38 - 0.41
52wk Range:0.25 - 1.75
Volume:401,610
Avg Vol (3m):1,364,130
Market Cap:108.89M
P/E (ttm):N/A
EPS (ttm):-0.32
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
CTICDown 1.28%108.89M
BMYUp 0.11%94.37B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.94
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.19
Quarterly EPS Est (Sep-16) :-0.07
Mean Recommendation*:3.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback